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INTRODUCTION 
Alchornea cordifolia (Schum. and Thonn.) Müll. 
Arg. (Euphorbiaceace), known as christmas bush 
is found abundantly along the coast in the West 
Africa sub-region. Known traditionally as 
“Gyamma”, Alchornea is used for a variety of 
diseases by traditional medical practitioners in 
Ghana. Powdered leaves of Alchornea cordifolia 
is used to treat diarrhoea, wounds, sores, cuts 
(Abbiw, 1990) and applied topically as an anti-
inflammatory agent (Neuwinger, 2000). Alchor-
nea is also reported to possess a multiplicity of 
biological effects.  It is an antibacterial (Ajali, 
2000; Igbeneghu et al., 2007), spasmolytic 
(Ogungbamila and Samuelsson, 1990), anti-
inflammatory (Manga et al., 2004; Osadebe and 
Okoye, 2003), hepatoprotective  (Olaleye et al., 
2006), antidiarrhoeal  (Agbor et al., 2004), anti-
oxidant (Olalye and Rocha, 2008)  and antimicro-
bial (Ebi, 2001). These diverse pharmacological 
actions have been linked to several active princi-
ples isolated from the leaves and root bark of Al-
chornea cordifolia. For example, Quetin-Leclercq 
et al., (2008) demonstrated the presence of anti-
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inflammatory compounds in Alchornea. In addi-
tion, tannins, phenolic acids: gallic acid, ellagic 
acid, protocatechic acid (Banzouzi et al., 2002; 
Lamikanra et al., 1990; Ogungbamila and 
Samuelsson, 1990), flavonoids: quercetin, hy-
perin and guaijaverin (Ajali, 2000; Lamikanra et 
al., 1990; Ogungbamila and Samuelsson, 1990) 
and an alkaloid: triisopentenylguanidine 
(Lamikanra et al., 1990) have been isolated from 
the leaves of Alchornea cordifolia.  
In spite of the wide traditional use of Alchornea 
crorditolia, very little is known about its potential 
toxicity. We demonstrated recently in our labora-
tory that administration of ethanolic leaf extracts 
of Alchornea to rats resulted in increased neutro-
phil count and mild hepatotoxicity (unpublished). 
It is presently unknown if this effect occurs in 
other rodent species. 
This study aimed at investigating the possible 
toxicity of Alchornea in mice since interspecies 
variation plays a key role in the toxicity of xeno-
biotics (Jemnitz et al., 2008; Ratanasavanh et al., 
1996; Vassallo et al., 2004). 
 
MATERIALS AND METHODS  
Preparation of Alchornea cordifolia extract 
The fresh leaves of Alchornea cordifolia were 
obtained from the Kwame Nkrumah University of 
Science and Technology Botanical Gardens and 
authenticated at the Department of Pharmacog-
nosy, Faculty of Pharmacy and Pharmaceutical 
Sciences, College of Health Sciences, Kwame 
Nkrumah University of Science and Technology, 
Kumasi, Ghana.  The leaves were sun-dried and 
then powdered with a hammer mill. Extraction of 
the powdered dried leaves was by cold macera-
tion with 70% alcohol. The alcohol was evapo-
rated with a rotary evaporator attached to a 
thermo chiller (Buchi 700, Recirculation chiller) 
at a temperature of 20 0C. The residue was freeze-
dried to obtain a brown sample of the crude-





ICR mice (20-30 g) were purchased from Nogu-
chi Memorial Institute for Medical Research, 
University of Ghana, Legon, and maintained in 
the Animal House of the Department of Pharma-
cology, Kwame Nkrumah University of Science 
of and Technology, Kumasi, Ghana. They were 
housed in stainless steel cages (34 x 47 x 18 cm) 
with soft wood shavings as bedding, fed with 
normal commercial pellet diet (GAFCO, Tema, 
Ghana) and given water ad libitum.  The animals 
were humanely handled throughout the experi-
ment in accordance with internationally accepted 
principles for laboratory animal use and care 
(EEC directive of 1986: 86/609 EEC). 
 
Subacute Toxicity 
Male mice (20-30 g) were divided into five 
groups. (n=5). The groups received 250, 500, 
1000, 2000 mg/kg of the extract in 2% tragacanth 
(p. o) daily for two weeks. The control group re-
ceived tragacanth 2% only throughout the two 
week period. The animals were monitored closely 
for signs of toxicity. At the end of the two-week 
period, the mice were euthanized by cervical dis-
location and blood was collected into tubes. 
 
Blood analysis 
Haematological analyses were performed on 
whole blood collected into tubes with EDTA. 
Haematocrit (HCT), platelets, mean corpuscular 
volume (MCV), mean corpuscular haemoglobin 
(MCH), Mean corpuscular haemoglobin concen-
tration(MCHC), white blood cell (WBC), Red 
blood cells (RBC), Lymphocytes (LYM), Granu-
locyte (GRAN), Mid cells (MID), Red cells dis-
tribution weight (RDW) and Platelets (PLT)  
were determined by an automatic analyzer (CELL 
DYN 1700, Abbott Diagnostics Division, Abbott 
Laboratories, Abbott Park, IL, USA). 
 
Biochemical Analysis 
Biochemical analysis were performed on serum 
obtained after centrifugation of whole blood 
(without anticoagulant) at 3000rpm for 5 min. 
Determination of total proteins, total bilirubin, 
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indirect bilirubin, albumin, globulin and A/G ratio 
were performed using an automatic analyzer 
(Random Access Chemistry System ATAC 8000, 
élan diagnostic laboratories, Brea, CA, USA). 
Levels of the liver enzymes alanine aminotrans-
ferase (ALT), aspartate transaminase, alkaline 
phosphatase (AP) and γ-glutamyl aminotrans-
ferase (GGT) were determined. Analysis for 
blood urea nitrogen (BUN), creatinine, sodium, 
potassium and chloride was also performed. 
 
Organ weight determination 
Vital organs including the liver, spleen, kidneys, 
heart, stomach, testes and lungs were quickly 
removed and weighed individually. Macroscopic 
appearances of the organs were observed and the 
relative weight of each organ was estimated.  
 
Histopathological assessment 
Livers and kidneys from treated and control ani-
mals were removed after dissection and immedi-
ately preserved in 10% formalin until processing. 
Tissues were dissected, placed into appropriate 
tissue preparation cassettes and processed with an 
auto processor (MICROM STP120, Spain) for 
embedding in paraffin. Sections of 7 µm were cut 
and stained with hematoxylin and eosin as previ-
ously described (Thompson, 1966). 
 
Statistical analysis 
Results were expressed as mean ± standard error 
of mean (S.E.M.). Statistical analysis was per-
formed by one-way ANOVA using Graph Pad 
Prism for Windows version 4.02 (Graph Pad soft-
ware, San Diego, CA, USA), followed by Neu-
man Keuls test to evaluate significant differences 
between the groups. Differences were considered 
significant for P< 0.05. 
 
RESULTS AND DISCUSSION 
Historically, medicinal plants have been used for 
the treatment and prevention of a variety of dis-
eases. Their beneficial effects support their con-
tinuing use by majority of people (Matthews et 
al., 1999).  The assumption that herbal medicines 
are safe as they are natural is disputed by well 
controlled clinical trials which confirmed the ex-
istence of adverse effects (Bagheri t al., 1998; 
Drew and Myers, 1997). 



















Figure 1: Weight of mice 
before and after 14-day 
treatment with Alchornea 
cordifolia. (n=5). Weights 
were taken before treatment 
at the indicated doses for a 
period of 14 days. Final body 
weights of the animals were 
then determined  
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In the present study, treated animals were ob-
served closely over the period for signs of toxic-
ity. We did not observe any abnormal behaviour, 
motor or neurological disorders. There was no 
diarrhoea or other signs of gastrointestinal disor-
ders, wheezing or other symptoms of respiratory 
distress suggesting that our treatment did not af-
fect the gastrointestinal or respiratory systems. 
There was no change in locomotor activity. No 
deaths were recorded throughout the study, food 
and water intake was also normal. Ordinarily, a 
loss of more than 10% of initial body weight in 
treated animals is an indication of adverse effects 
(Raza et al., 2002; Teo et al., 2002). We found no 
differences between the body-weight of treated 
and control animals (Figure 1). Our findings sug-
gest that the extract did not provoke autonomic 
and/or central effects nor affected the general 
health of mice at the doses used since we found 
no evidence of signs of toxicity associated with 
these systems. 
Organ  Doses (mg/kg) 
Control  250 500 1000  2000 
HEART 0.47±0.04 0.49±0.06 0.47±0.02 0.40±0.04 0.38±0.03 
LIVER 4.46±0.59 5.08±0.67 5.71±0.63 4.67±0.82 4.20±0.48 
KIDNEY  1.20±0.01 1.21±0.09 1.23±0.09 1.09±0.13 1.07±0.06 
SPLEEN 0.64±0.13 0.74±0.11 0.97±0.26 0.73±0.21 0.74±0.09 
STOMACH 1.12±0.07 1.17±0.10 0.92±0.31 1.25±0.12 1.44±0.03 
TESTIS 0.61±0.03 0.60±0.03 0.62±0.02 0.58±0.05 0.44±0.10 
LUNGS 0.61±0.03 0.79±0.07 0.70±0.03 0.82±0.09 0.70±0.04 
Table 1: Effect of Alchornea cordifolia on relative organ weights of mice treated for two 
weeks. Values are expressed as mean ± SEM (n=5) compared to the control by the Neuman 
Kuels test 
 Parameter 
Doses (mg/kg)  
Control  250 500 1000 2000 
WBC(K/µL) 5.10±0.63 6.83±0.70 6.80±1.07 8.40±1.08  9.00±2.55 
LYM (%) 79.10±2.80 78.35±3.06 79.60±0.87 80.68±1.15 75.83±1.48 
MID (%) 15.22±2.22 15.68±1.58 15.53±0.42 15.14±0.65 19.70±1.78 
NEU (%) 5.68±1.40 5.98±2.09 4.98±1.03 4.18±0.66 4.47±0.73 
RBC (M/µL) 6.81±0.14 5.55±0.51 6.34±0.39 5.97±0.31 6.66±0.14 
HGB (g/dL) 11.44±0.30 10.05±0.67 11.28±0.92 10.2±0.69 10.83±0.09 
HCT (%) 30.53±0.79 23.60±1.90 26.55±2.45 26.85±0.64 29.53±0.52 
MCV(fl) 44.40±0.47 42.45±0.35 42.98±0.91 45.32±1.07 44.40±1.69 
MCH(pg) 16.33±0.50 16.30±0.60 15.50±0.50 16.08±0.37 16.27±0.47 
MCHC(g/dL) 36.47±0.59 38.25±0.95 36.77±0.29 35.63±0.53 36.70±0.36 
RDW (%) 19.04±1.31 18.68±0.94 20.03±1.04 17.94±1.03 19.23±1.02 
Table 2: Effect of Alchornea cordifolia on haematological parameters in mice treated for 
two weeks. Values are expressed as mean ± SEM (n= 5), compared to the control by Neu-
man Kuels test. 
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Organ swelling due to inflammation and hyper-
trophy could result in increased organ weight. In 
contrast, atrophy leads to reduction in organ 
weight. In our study, the relative weights of or-
gans of treated animals did not differ significantly 
from control animals (Table 1), indicating that 
Alchornea cordifolia at the doses used did not 
produce damage in the form of organ swelling, 
atrophy or hypertrophy in the treated animals. 
The haematopoietic system is an important index 
of physiological and pathological status in man 
and animals (Adeneye t al., 2006) and a sensi-
tive target for toxic compounds (Harper, 1973) 
since it is initially exposed to a high concentration 
of toxic agents. Results of the studies indicate that
Alchornea cordifolia had no effect on the haema-
tological parameters tested (Table 2) and there-
fore barring any species differences is unlikely to 
present toxicity to blood and its cellular elements. 
 Indicators of liver function, AST and ALT  
(Palmeiro et al., 2003)  are used as biomarkers for 
predicting possible toxicity to the liver (Rahman 
et al., 2001).  Damage to the liver  parenchyma 
cells will induce leakage of these enzymes into 
serum leading to their  elevation several fold 
(Wolf, 1999). These parameters did not change 
appreciably in the treated groups as compared to 
the control (Table 3), indicating that Alchornea 
cordifolia has no effect on these biochemical pa-
rameters and is therefore not a potential hepato-
toxin. 
The lack of elevation of hepatic transaminase 
levels observed in the present study would sug-
gest that Alchornea had no adverse effect on the 
liver. However, initial and transient damage to the 
liver may not necessarily reflect in increases in 
the levels of liver enzymes. We assessed the liver 
sections of mice treated with Alchornea extract. 
Liver sections of mice were not different from 
control groups up to a dose of 1000mg/kg. How-
ever, in the 2000 mg/kg group, there were 
perivascular aggregates of lymphocytes (Figure 
2) and some of the nuclei showed pyknosis with 
eosinophilic cytoplasm. Though this observation 
did not correlate with the biochemical findings, 
the degeneration observed in the histopathologi-
cal evaluation is a clear sign of liver cell injury. 
In the present state, termination of the injuring 
agent will result in the regeneration of liver cells 
(Cotran et al., 1996). These results suggest that 
 Parameter 
  Doses (mg/kg)  
Control  250 500 1000 2000 
Total biIirubin µmol/L 28.04±6.48 26.51±5.94 32.49±5.46 32.49±10.59 28.22±3.59 
Direct bilirubin µmol/L 10.26±2.65 13.68±4.58 11.97±2.29 14.54±4.76 13.25±4.15 
Total protein g/L 82.60±3.17 75.50±5.49 73.20±4.91 84.25±2.10 84.25±2.06 
Albumin g/L 47.00±4.63 48.50±7.53 44.20±3.29 54.00±2.83 50.50±2.90 
Globulin g/L 3.56±0.54 2.70±0.55 2.90±0.34 3.03±0.47 3.38±0.40 
Albumin/Globulin 1.56±0.40 2.18±0.76 1.60±0.19 2.03± .48 1.58±0.28 
Indirect Bilirubin µmol/L 17.78±4.64 12.83±4.85 20.52±5.03 17.98±5.85 14.98±1.89 
AST U/L 46.40±2.87 47.75±2.14 42.80±2.67 45.00±4.24 39.25±1.25 
ALT U/L 49.60±3.93 44.25±2.21 39.40±2.50 44.25±1.11 39.00±2.48 
ALP U/L 118.40±4.79 118.40±4.79 104.40±2.75 116.00±7.10 108.00±5.82 
GGT U/L 32.40±6.93 24.25±2.84 26.40±0.87 30.67±2.73 30.00±3.39 
Table 3: Effect of Alchornea cordifolia on serum biochemistry of mice treated for two weeks. 
Values are expressed as mean ± SEM (n=5), compared to the control by the Neuman Kuels test. 
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Figure 2: Photomicrograph 
(x 400) showing liver sections 
of mice after 14-day treat-
ment with Alchornea cordifo-
lia leaf extract. Panel A 
(control), Panel B (250mg/
kg), Panel C (500mg/kg) 
Panel D (1000mg/kg) and 
Panel E (2000mg/kg).   
high doses of Alchornea extract administered 
over a long period have the propensity to be hepa-
totoxic. 
Biochemical studies on the renal system did not 
show any evidence of renal damage. Lack of sig-
nificant changes in creatinine, BUN, sodium, po-
tassium and chloride ions  (Table 4)  of treated 
mice in relation to  the control groups suggests 
good renal function (Hilaly et al., 2004) and con-
firms that Alchornea extract has no adverse effect 
on renal function. To confirm our observation, we 
examined photomicrographs prepared from kid-
ney sections of treated and control animals. We 
found no alterations suggesting kidney damage in 
the groups treated with Alchornea extract (Figure 
3). 
Overall, our study has shown that apart from the 
potential hepatotoxicity of Alchornea cordifolia 
depicted by eosinophilia, lymphocyte aggregation 
and pyknosis of microscopic sections of the liver, 
it is generally non-toxic to mice at the doses used. 
Parameter 
Doses (mg/kg 
 Control  250 500 1000 2000 
Sodium mmol/L 142.00±2.30 141.30±2.14 140.40±1.99 141.30±3.15 139.50±1.85 
Potassium mmol/L 5.04±0.65 4.85±0.50 4.84±0.35 5.45±0.19 5.15±0.24 
Chloride mmol/L 112.00±4.51 99.50±1.85 101.80±1.11 108.30±8.06 104.00±2.35 
Blood urea nitrogen 
(BUN) mmol/L 
3.46±0.60 4.73±1.14 3.28±0.40 4.30±0.58 4.50±0.39 
Creatitine µmol/L 120.60±27.94 68.30±5.13 99.02±6.49 99.45±9.10 108.30±11.04 
BUN /creatinine 8.80±2.922 16.75±3.12 8.40±1.33 10.00±1.30 10.50±1.32 
Table 4: Effect of Alchornea cordifolia extract on renal function parameters of mice treated for 
two weeks. Values are expressed as mean ± SEM (n=5), compared to the control by the Neuman 
kuels test.  
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Figure 3: Photomicrograph (x 400) 
showing kidney sections of mice (H 
& E) after 14-day treatment with 
Alchornea cordifolia leaf extract. 
Panel A (control), Panel B (250mg/
kg), Panel C (500mg/kg), Panel D 
(1000mg/kg) and Panel E (2000mg/
kg).   
CONCLUSION  
The studies show that Alchornea cordifolia is 
relatively safe in mice at the doses used. Though 
this finding cannot be directly extrapolated to 
man, caution needs to be taken when high doses 
are administered over long periods as the extract 
has the potential to provoke liver damage. 
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